A detailed history of Axq Capital, LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Axq Capital, LP holds 9,425 shares of ABBV stock, worth $1.7 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
9,425
Holding current value
$1.7 Million
% of portfolio
0.56%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $1.54 Million - $1.88 Million
9,425 New
9,425 $1.86 Billion
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $591,334 - $673,770
3,700 New
3,700 $674 Million
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $384,279 - $478,210
2,900 New
2,900 $391 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $951,711 - $1.14 Million
6,881 New
6,881 $1.11 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Axq Capital, LP Portfolio

Follow Axq Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Axq Capital, LP with notifications on news.